The Safety and Efficacy of Combination Therapy of Sorafenib and Radiotherapy for Advanced Hepatocellular Carcinoma: A Retrospective Study

OBJECTIVE: Sorafenib is a standard therapy for advanced hepatocellular carcinoma (HCC), whereas radiotherapy is effective for local control of extrahepatic spread (EHS) or macrovascular invasion (MVI). This study investigated the safety and efficacy of this combined therapy to treat advanced HCC. ME...

Descripción completa

Detalles Bibliográficos
Autores principales: Wada, Yoshiyuki, Takami, Yuko, Matsushima, Hajime, Tateishi, Masaki, Ryu, Tomoki, Yoshitomi, Munehiro, Matsumura, Taisei, Saitsu, Hideki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5995712/
https://www.ncbi.nlm.nih.gov/pubmed/29279513
http://dx.doi.org/10.2169/internalmedicine.9826-17

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5995712/
https://www.ncbi.nlm.nih.gov/pubmed/29279513
http://dx.doi.org/10.2169/internalmedicine.9826-17

Ejemplares similares